Research efforts to validate reference range and standardize urinary nephrin assays are essential to realize its clinical utilityand integrate it into routine clinical practice for the early detection and management of DN and also its mitigation in extra-renaltissues. The gene discussed is NPHS1; the disease is liver dysplastic nodule.